AIM

AIM ImmunoTech Inc.

21 hedge funds and large institutions have $557K invested in AIM ImmunoTech Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$263K 1,143,632 -794,742 -41%
Vanguard Group
2
Vanguard Group
Pennsylvania
$110K 479,679 +12,105 +3%
BlackRock
3
BlackRock
New York
$105K 458,919 +471 +0.1%
Citadel Advisors
4
Citadel Advisors
Florida
$24K 103,887 +48,867 +89%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$17K 74,832
Creative Planning
6
Creative Planning
Kansas
$9K 40,001
Northern Trust
7
Northern Trust
Illinois
$7K 31,933
UBS Group
8
UBS Group
Switzerland
$7K 33,169 +12,511 +61%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$6K 24,100 +24,100 New
OAM
10
Occidental Asset Management
California
$4K 15,834
Invesco
11
Invesco
Georgia
$3K 12,113 -1,513 -11%
WPW
12
Waldron Private Wealth
Pennsylvania
$2K 11,000
VF
13
Virtu Financial
New York
-30,718 Closed
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
-2,000 Closed
ML
15
McAdam LLC
Pennsylvania
-342 Closed
CFGS
16
Concourse Financial Group Securities
Alabama
HNB
17
Huntington National Bank
Ohio
$0 2,501
CHC
18
City Holding Co
West Virginia
$0 417
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
$0 209
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$0 1,080
AG
21
Advisor Group
Arizona
$0 250
SIS
22
Sound Income Strategies
Florida
$0 9
JCM
23
Jacobi Capital Management
Pennsylvania
$0 318
Morgan Stanley
24
Morgan Stanley
New York
$0 1,101 +17 +2%
Deutsche Bank
25
Deutsche Bank
Germany
$0 301 +301 New